Sept 8 (Reuters) - SENSORION SA ALSEN.PA :
- SENSORION AND COCHLEAR TO BEGIN FIRST CLINICAL TRIAL OF SENS-401 FOR HEARING PRESERVATION IN COMBINATION WITH COCHLEAR IMPLANTATION
- STUDY WILL AIM TO MEASURE PERILYMPH PK OF SENS401 AND TO EXPLORE THERAPEUTIC EFFECT OF SENS-401 ON EARLY HEARING OUTCOMES UPON COCHLEAR IMPLANTATION
- TRIAL WILL BE FULLY FUNDED UNDER EXISTING AGREEMENT BETWEEN COCHLEAR AND SENSORION
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$317.00 |
Change
4.170(1.33%) |
Mkt cap ! $20.65B | |||
| Open | High | Low | Value | Volume |
| $314.28 | $318.91 | $313.71 | $43.37M | 136.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 324 | $317.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $317.09 | 153 | 2 |
View Market Depth
| Last trade - 16.10pm 28/07/2025 (20 minute delay) ? |
| COH (ASX) Chart |